- cafead   Apr 14, 2022 at 11:22: AM
via Amneal Pharmaceuticals received the green light from the U.S. Food and Drug Administration for bevacizumab-maly, a biosimilar to Genentech (Roche)’s Avastin. The biosimilar approval marks the second for Amneal this year.
article source
article source